Symposium:
199. Hepatitis Viruses in Transplantation
Saturday, October 29, 2016: 8:30 AM-10:00 AM
Room: 391-392

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • recognize indications of antiviral treatment for hepatitis B and C in immunocompromised hosts
  • describe antiviral management options for hepatitis virus infections in immunocompromised hosts
  • discuss strategies for preventing hepatitis B and C recurrence after organ and tissue transplantation

Target Audience: Academicians, Clinicians, Fellows, Healthcare workers, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Lab personnel, Members-in-training, Microbiologists, Nurses, Pharmacists, Researchers, Scientists, Vaccinologists

Tracks: Investigative ID, Epidemiology and Infection Control, Adult ID

Moderators:  Raymund R. Razonable, MD, FIDSA, Mayo Clinic and David Van Duin, MD, PhD, University of North Carolina

Presentations:
8:30 AM
Hepatitis C in Liver Transplantation
Norah a. Terrault, MD, MPH

8:55 AM
Q&A
9:25 AM
Q&A
9:55 AM
Q&A

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.5 knowledge-based contact hours 0.15 of pharmacy CE

ACPE Number: 0221-9999-16-283-L01-P

Disclosures:

R. R. Razonable, None

D. Van Duin, astellas: Scientific Advisor , Consulting fee
tetraphase: Scientific Advisor , Consulting fee
actavis: Scientific Advisor , Consulting fee
medimmune: Scientific Advisor , Consulting fee
Sanofi-Pasteur: Scientific Advisor , Consulting fee
scynexis: Investigator , Research support
steris: Grant Investigator , Research grant

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.